2021 - Sam Behjati

Group Leader at Wellcome Sanger Institute, UK

His research sits at the interface of cancer genomics and single cell transcriptomics. Dr Behjati’s team uses cutting edge single cell techniques to understand normal human development and how normal development relates to disease.  The focus is on understanding and quantifying the nature and origins of cancer cells, particularly childhood cancers.  To do this, the research combines the study of somatic genomic changes, bulk and single cell transcriptomics, and mathematical modelling of data.

About the 2021 Winner

2020    EMBO Young Investigator 
2019    Liddy Shriver Early Research Award, Connective Tissue Oncology Society
            Honorary Consultant Paediatric Oncologist, Cambridge University Hospitals NHS Trust
            Dr Simon Newell Early Career Investigator of the Year (Sparks) award,
    Royal College of Paediatrics and Child Health (UK)
2018    Group Leader in Cellular Genetics, Wellcome Sanger Institute
2016    Research Fellow, Corpus Christi College, Cambridge

            AAAS & SciLifeLab Prize for Young Scientists
            Intermediate Clinical Fellowship, Wellcome Trust
            Robert J. Arceci Innovation Award, St. Baldrick’s Foundation (USA)
2015    Donald Paterson Prize, Royal College of Paediatrics and Child Health
2014    PhD / Wellcome Clinical Research Fellow, University of Cambridge
2006-2019 Post-graduate clinical academic training in paediatric oncology and haematology

2006    BMBCh, University of Oxford

Interview with the winner Sam Behjati

Last update 28/04/2021

The 2021 winner of the Pezcoller Foundation-EACR Rising Star Award, Dr. Sam Behjati

The award lecture will be given at the EACR Congress, taking place from 9-12 June 2021. Dr. Behjati will be presented with his award by The Pezcoller Foundation President, Enzo Galligioni.

It is a great honour to receive the Pezcoller Foundation-EACR Rising Star Award 2021. I hope to repay the faith shown in the potential of my research in the years to come by continuing to improve our understanding of childhood cancers and, most importantly, outcomes for those children diagnosed with these terrible diseases. I would like to thank the many colleagues and collaborators who have contributed to this research, and above all the patients and families without whom this research could not have taken place.”
- Dr. Sam Behjati - 

unchecked checked